Boston Scientific has received clearance to launch its Emerge Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Dilatation Catheter in the US. The device received EU clearance earlier this year.
The Emerge, designed for accessing difficult lesions within coronary arteries, is available in diameters of 1.5 mm to 4.0 mm and balloons in length from 8 mm to 30 mm.
From the press release:
Both the Monorail and OTW catheters are available with two distinct shaft technologies designed to provide versatility in addressing different clinical situations. The “Push Technology” (1.5 mm) offers a single-segment inner shaft for enhanced pushability. The “Workhorse Technology” (1.5 mm to 4.0 mm) features a bi-segment inner shaft designed for excellent deliverability without sacrificing push.
“The Emerge Balloon Catheter combines Boston Scientific’s innovative balloon technologies into a single platform,” said J. Tift Mann, III, M.D., at Wake Heart & Vascular, Raleigh, North Carolina. “The result is exceptional deliverability and reliable performance in a wide range of anatomy and lesion types.”
Press release: Boston Scientific Launches Emerge™ PTCA Balloon Dilatation Catheter in the U.S.
Product page: Emerge PTCA Dilatation Catheter